Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
Alumni Ventures Portfolio in Action: Salvo Health Salvo Health is redefining integrated care with its hybrid model, blending telemedicine and in-person services to manage chronic gastrointestinal and metabolic liver conditions
Overall, tirzepatides dual agonism of GLP1 and GIP receptors appears to provide encouraging cardiovascular benefits beyond glycemic control, offering a potential new therapeutic option for treating cardiovascular diseases and heart failure
swelling of the face, lips or throat, difficulty breathing, difficulty swallowing or palpitations)
KEY FINDINGS To start, we analysed publically available sequencing data of cancer patient samples and found that the expression of serine and glycine synthesis enzymes was significantly increased in T-cell leukaemia patient samples that present NKX2-1 overexpression (Figure 2)
